Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,495.25
+537.98
(+1.08%)
MONEY
Best savings accounts that offer above inflation rates
Where to find a top-rated deal that works for you
Aldeyra Therapeutics, Inc. (ALDX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1600
-0.0500
(-1.19%)
At close: 04:00PM EDT
4.0900
-0.07
(-1.68%)
After hours:
07:32PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
29,459
29,459
47,306
44,937
24,681
Selling general and administrative
13,335
13,335
15,374
11,283
9,985
Total operating expenses
42,794
42,794
62,680
56,220
34,667
Operating income or loss
-42,794
-42,794
-62,680
-56,220
-34,667
Interest expense
2,071
2,071
1,694
1,742
1,904
Total other income/expenses net
-
-
-
-
-1,754
Income before tax
-37,543
-37,543
-62,025
-57,776
-38,033
Income tax expense
-
-
-
0
-479.265
Income from continuing operations
-37,543
-37,543
-62,025
-57,776
-37,554
Net income
-37,543
-37,543
-62,025
-57,776
-37,554
Net income available to common shareholders
-37,543
-37,543
-62,025
-57,776
-37,554
Basic EPS
-0.78
-0.64
-1.06
-1.07
-1.11
Diluted EPS
-0.78
-0.64
-1.06
-1.07
-1.11
Basic average shares
58,785
58,943
58,406
54,042
33,966
Diluted average shares
58,785
58,943
58,406
54,042
33,966
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.